Market revenue in 2023 | USD 93.5 million |
Market revenue in 2030 | USD 155.0 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Synthetic/ blend of natural & synthetic |
Fastest growing segment | Natural |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Natural, Synthetic/ Blend of Natural & Synthetic |
Key market players worldwide | Fairhaven Health, Vitabiotics, Mankind Pharma, extreme V, Coast Science, Orthomol, Exeltis, bioNova, Innovamed, PlusPlus LifeSciences, Eu Natural |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fertility supplements market will help companies and investors design strategic landscapes.
Synthetic/ blend of natural & synthetic was the largest segment with a revenue share of 89.52% in 2023. Horizon Databook has segmented the Italy fertility supplements market based on natural, synthetic/ blend of natural & synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
According to a Frontiers in Endocrinology report from April 2022, researchers in Italy have created a scoring system for supplements indicated to increase male fertility. The study showed that folic acid, inositol, and N-acetyl cysteine (NAC) are among the most promising components.
The researchers recognized several problems, including decreased sperm motility, DNA damage, genital tract infections, and inflammations, linked to male infertility. Product developers suggested over 20 distinct ingredients, all claiming to help with these fertility-related problems.
In April 2022, the National Institute of Health (NIH) reported that prescription drugs for pregnant Italian and immigrant women varied significantly. Among Italians, progesterone is prescribed more frequently (16.5% vs. 8.1% for immigrants) for early pregnancy loss. Different healthcare practices may be reflected in this divergence in prescription patterns.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy fertility supplements market , including forecasts for subscribers. This country databook contains high-level insights into Italy fertility supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account